Last reviewed · How we verify

NCT03701958

Initial Case Series With Exalt Single-Use Duodenoscope

Completed NA Last updated 8 February 2022
What this trial tests

NA trial testing Exalt Model D Single-Use Duodenoscope in Endoscopic Retrograde Cholangiopancreatography in 60 participants. Completed in 7 June 2019.

Timeline
15 April 2019
Primary endpoint
6 May 2019
7 June 2019

Quick facts

Lead sponsorBoston Scientific Corporation
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposedevice feasibility
Enrollment60
Start date15 April 2019
Primary completion6 May 2019
Estimated completion7 June 2019
Sites6 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Boston Scientific Corporation — full company profile →

Who can join

18 and older, any sex, with Endoscopic Retrograde Cholangiopancreatography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To confirm procedural performance of the Exalt single-use duodenoscope in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) procedures.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Clinical Evaluation of a Single-Use Duodenoscope for Endoscopic Retrograde Cholangiopancreatography.
    Muthusamy VR, Bruno MJ, Kozarek RA, Petersen BT, et al · · 2020 · cited 64× · PMID 31706060 · DOI 10.1016/j.cgh.2019.10.052
  2. Late breaking abstracts
    · 2019 · cited 2×

Verify or expand the search:

Other trials of Exalt Model D Single-Use Duodenoscope

Trials testing the same drug.

Other recruiting trials for Endoscopic Retrograde Cholangiopancreatography

Currently open trials in the same condition.

Other Boston Scientific Corporation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03701958.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing